DNA Methylation in Peripheral Blood and Risk of Gastric Cancer: A Prospective Nested Case-control Study.

Area of Science:

• Epigenetics and Cancer Epidemiology

Background:

• Gastric cancer diagnosis often occurs at late stages, leading to poor prognosis.
• DNA methylation in peripheral blood has been explored as a potential non-invasive biomarker for early gastric cancer detection and risk assessment.

Purpose of the Study:

• To investigate the prospective association between genome-wide DNA methylation in peripheral blood and gastric cancer risk.

Main Methods:

• A nested case-control study within the Melbourne Collaborative Cohort Study.
• Genome-wide DNA methylation analysis using the Infinium HumanMethylation450K Beadchip on blood samples collected years before diagnosis.
• Statistical analysis including conditional logistic regression for individual CpGs, differentially methylated regions (DMRs), and global methylation measures.

Main Results:

• No significant associations were found between individual CpG methylation, DMRs, or global methylation measures and gastric cancer risk.
• The odds ratio for gastric cancer risk per standard deviation increase in overall median methylation was 1.07 (95% CI, 0.80-1.44; P = 0.65).

Conclusions:

• Peripheral blood DNA methylation is not a prospective biomarker for gastric cancer risk.
• The search for reliable early detection markers for gastric cancer, a disease with poor survival rates at later stages, must continue.